{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:11:35Z","timestamp":1790291495072,"version":"4.1.0"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004784","name":"Novartis Stiftung\u00a0f\u00fcr\u00a0Medizinisch-Biologische Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012654","name":"Olga Mayenfisch Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012654","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Aging causes chronic low-grade inflammation known as inflamm-aging. It is a risk factor for several chronic disorders, including chronic myelomonocytic leukemia (CMML), a hematological malignancy that is most prevalent in older people. Recent studies suggest a critical role for the NLRP3 (NOD-, LRR- and pyrin domain-containing protein 3) inflammasome in inflamm-aging. However, the mechanisms involved in NLRP3 activation in aging and its involvement in CMML progression are not fully understood. In this study, we report that aging increases IL-1\u03b2 production upon NLRP3 activation in human CD14+ monocytes. Interestingly, we found that the TLR1\/2 agonist Pam3CSK4 directly activates the NLRP3 inflammasome in monocytes from older but not from younger healthy donors. Furthermore, we observed a dichotomous response to NLRP3 inflammasome activation in monocytes from a small cohort of CMML patients, and some patients produced high levels of IL-1\u03b2 and some patients produced low levels of IL-1\u03b2 compared with older healthy donors. Intriguingly, CMML patients with heightened NLRP3 activation showed increased treatment dependency and disease severity. Collectively, our results suggest that aging causes increased sensitivity to NLRP3 inflammasome activation at a cellular level, which may explain increased inflammation and immune dysregulation in older individuals. Furthermore, NLRP3 inflammasome activation was dysregulated in a small cohort of CMML patients and was positively correlated with disease severity.<\/jats:p>","DOI":"10.4049\/jimmunol.2200412","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T13:32:08Z","timestamp":1674221528000},"page":"580-589","source":"Crossref","is-referenced-by-count":16,"title":["Increased Inflammasome Activation Is Associated with Aging and Chronic Myelomonocytic Leukemia Disease Severity"],"prefix":"10.1093","volume":"210","author":[{"given":"Nicola","family":"Andina","sequence":"first","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern , Bern,","place":["Switzerland"]},{"name":"Department for BioMedical Research, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"de Meuron","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern , Bern,","place":["Switzerland"]},{"name":"Department for BioMedical Research, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7716-3340","authenticated-orcid":false,"given":"Annatina Sarah","family":"Schnegg-Kaufmann","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5653-8991","authenticated-orcid":false,"given":"Mayuresh Anant","family":"Sarangdhar","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern , Bern,","place":["Switzerland"]},{"name":"Department for BioMedical Research, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Ansermet","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern , Bern,","place":["Switzerland"]},{"name":"Department for BioMedical Research, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0752-4769","authenticated-orcid":false,"given":"Giuseppe","family":"Bombaci","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern , Bern,","place":["Switzerland"]},{"name":"Department for BioMedical Research, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3494-0979","authenticated-orcid":false,"given":"Kiran","family":"Batta","sequence":"additional","affiliation":[{"name":"Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester , Manchester,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Keller","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2515-1935","authenticated-orcid":false,"given":"Naomi A","family":"Porret","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Angelillo-Scherrer","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern , Bern,","place":["Switzerland"]},{"name":"Department for BioMedical Research, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bonadies","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern , Bern,","place":["Switzerland"]},{"name":"Department for BioMedical Research, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2789-3596","authenticated-orcid":false,"given":"Ramanjaneyulu","family":"Allam","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern , Bern,","place":["Switzerland"]},{"name":"Department for BioMedical Research, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"2025021008000478200_r1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.15252\/embr.201439518","article-title":"Living too long: the current focus of medical research on increasing the quantity, rather than the quality, of life is damaging our health and harming the economy","volume":"16","author":"Brown","year":"2015","journal-title":"EMBO Rep."},{"key":"2025021008000478200_r2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.coi.2010.05.003","article-title":"Aging of the innate immune system","volume":"22","author":"Shaw","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"2025021008000478200_r3","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"key":"2025021008000478200_r4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2025021008000478200_r5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"2025021008000478200_r6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"2025021008000478200_r7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000497375","article-title":"Human inflammaging","volume":"65","author":"F\u00fcl\u00f6p","year":"2019","journal-title":"Gerontology"},{"key":"2025021008000478200_r8","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3389\/fimmu.2017.01960","article-title":"Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes?","volume":"8","author":"Fulop","year":"2018","journal-title":"Front. Immunol."},{"key":"2025021008000478200_r9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cmet.2013.09.010","article-title":"Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging","volume":"18","author":"Youm","year":"2013","journal-title":"Cell Metab."},{"key":"2025021008000478200_r10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.smim.2018.09.001","article-title":"NLRP3 inflammasome activation in inflammaging","volume":"40","author":"Latz","year":"2018","journal-title":"Semin. Immunol."},{"key":"2025021008000478200_r11","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3390\/cells9061552","article-title":"The NLRP3 inflammasome as a critical actor in the inflammaging process","volume":"9","author":"Sebastian-Valverde","year":"2020","journal-title":"Cells"},{"key":"2025021008000478200_r12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"2025021008000478200_r13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"2025021008000478200_r14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"2025021008000478200_r15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev-physiol-021113-170324","article-title":"Inflammasomes and metabolic disease","volume":"76","author":"Henao-Mejia","year":"2014","journal-title":"Annu. Rev. Physiol."},{"key":"2025021008000478200_r16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.immuni.2016.01.012","article-title":"Human monocytes engage an alternative inflammasome pathway","volume":"44","author":"Gaidt","year":"2016","journal-title":"Immunity"},{"key":"2025021008000478200_r17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2016.10.007","article-title":"Alternative inflammasome activation enables IL-1\u03b2 release from living cells","volume":"44","author":"Gaidt","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"2025021008000478200_r18","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.4049\/jimmunol.1501336","article-title":"Aging-associated TNF production primes inflammasome activation and NLRP3-related metabolic disturbances","volume":"197","author":"Bauernfeind","year":"2016","journal-title":"J. Immunol."},{"key":"2025021008000478200_r19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-4933-9-27","article-title":"Defective pro-IL-1\u03b2 responses in macrophages from aged mice","volume":"9","author":"Ramirez","year":"2012","journal-title":"Immun. Ageing"},{"key":"2025021008000478200_r20","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.4049\/jimmunol.1103051","article-title":"Impaired NLRP3 inflammasome function in elderly mice during influenza infection is rescued by treatment with nigericin","volume":"188","author":"Stout-Delgado","year":"2012","journal-title":"J. Immunol."},{"key":"2025021008000478200_r21","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/s41375-020-0827-8","article-title":"The Nlrp3 inflammasome as a \u201crising star\u201d in studies of normal and malignant hematopoiesis","volume":"34","author":"Ratajczak","year":"2020","journal-title":"Leukemia"},{"key":"2025021008000478200_r22","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. [Published erratum appears in 2010 Nature 466: 652.]","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"2025021008000478200_r23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"key":"2025021008000478200_r24","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41467-020-15497-1","article-title":"Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat. Commun."},{"key":"2025021008000478200_r25","doi-asserted-by":"crossref","first-page":"825611","DOI":"10.3389\/fcell.2021.825611","article-title":"Inflammasome activation in myeloid malignancies\u2014friend or foe?","volume":"9","author":"Andina","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"2025021008000478200_r26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.leukres.2016.05.013","article-title":"Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: a series of 26 cases and literature review","volume":"47","author":"Grignano","year":"2016","journal-title":"Leuk. Res."},{"key":"2025021008000478200_r27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/blood-2017-04-736421","article-title":"How I treat chronic myelomonocytic leukemia","volume":"130","author":"Solary","year":"2017","journal-title":"Blood"},{"key":"2025021008000478200_r28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.seminhematol.2018.05.002","article-title":"Increased cardiovascular comorbidities in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia presenting with systemic inflammatory and autoimmune manifestations","volume":"55","author":"Kipfer","year":"2018","journal-title":"Semin. Hematol."},{"key":"2025021008000478200_r29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canep.2019.01.003","article-title":"Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: a comparison between Swiss and American population-based cancer registries","volume":"59","author":"Benzarti","year":"2019","journal-title":"Cancer Epidemiol."},{"key":"2025021008000478200_r30","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. [Published erratum appears in 2016 Blood 128: 462\u2013463.]","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"2025021008000478200_r31","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/leu.2008.119","article-title":"The myelodysplastic\/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features","volume":"22","author":"Orazi","year":"2008","journal-title":"Leukemia"},{"key":"2025021008000478200_r32","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017","edition":"4th"},{"key":"2025021008000478200_r33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.anndiagpath.2018.09.011","article-title":"Diagnostically relevant updates to the 2017 WHO classification of lymphoid neoplasms","volume":"37","author":"Choi","year":"2018","journal-title":"Ann. Diagn. Pathol."},{"key":"2025021008000478200_r34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2020.12.003","article-title":"The impact of ageing on monocytes and macrophages","volume":"230","author":"De Maeyer","year":"2021","journal-title":"Immunol. Lett."},{"key":"2025021008000478200_r35","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"key":"2025021008000478200_r36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-12-417028-5.00003-X","article-title":"A close encounter of the third kind: monocyte-derived cells","volume":"120","author":"Mildner","year":"2013","journal-title":"Adv. Immunol."},{"key":"2025021008000478200_r37","doi-asserted-by":"crossref","first-page":"e0176460","DOI":"10.1371\/journal.pone.0176460","article-title":"Phenotype, function, and differentiation potential of human monocyte subsets","volume":"12","author":"Boyette","year":"2017","journal-title":"PLoS One"},{"key":"2025021008000478200_r38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"2025021008000478200_r39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.270.5234.286","article-title":"Immunosuppression by glucocorticoids: inhibition of NF-\u03ba B activity through induction of I\u03baB synthesis","volume":"270","author":"Auphan","year":"1995","journal-title":"Science"},{"key":"2025021008000478200_r40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"2025021008000478200_r41","first-page":"1365","article-title":"Impact of proteasome inhibitor MG-132 on expression of NF-\u03baB, IL-1\u03b2 and histological remodeling after myocardial infarction","volume":"16","author":"Wu","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"2025021008000478200_r42","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.febslet.2011.05.047","article-title":"Inhibition of NF-\u03baB by MG132 through ER stress-mediated induction of LAP and LIP","volume":"585","author":"Nakajima","year":"2011","journal-title":"FEBS Lett."},{"key":"2025021008000478200_r43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1348-0421.2004.tb03598.x","article-title":"Piceatannol prevents lipopolysaccharide (LPS)-induced nitric oxide (NO) production and nuclear factor (NF)-\u03baB activation by inhibiting I\u03baB kinase (IKK)","volume":"48","author":"Islam","year":"2004","journal-title":"Microbiol. Immunol."},{"key":"2025021008000478200_r44","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature09857","article-title":"RIP3 mediates the embryonic lethality of caspase-8-deficient mice","volume":"471","author":"Kaiser","year":"2011","journal-title":"Nature"},{"key":"2025021008000478200_r45","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood.V99.3.840","article-title":"Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients","volume":"99","author":"Onida","year":"2002","journal-title":"Blood"},{"key":"2025021008000478200_r46","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.leukres.2014.09.003","article-title":"Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias","volume":"38","author":"Schuler","year":"2014","journal-title":"Leuk. Res."},{"key":"2025021008000478200_r47","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"2025021008000478200_r48","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"2025021008000478200_r49","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood-2012-08-452938","article-title":"Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia","volume":"121","author":"Such","year":"2013","journal-title":"Blood"},{"key":"2025021008000478200_r50","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2016-05-714030","article-title":"Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia","volume":"128","author":"Elena","year":"2016","journal-title":"Blood"},{"key":"2025021008000478200_r51","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1038\/bcj.2016.82","article-title":"Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance","volume":"6","author":"Patnaik","year":"2016","journal-title":"Blood Cancer J."},{"key":"2025021008000478200_r52","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1080\/10428194.2018.1452212","article-title":"Nonhepatosplenic extramedullary manifestations of chronic myelomonocytic leukemia: clinical, molecular and prognostic correlates","volume":"59","author":"Hoversten","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"2025021008000478200_r53","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1474-9726.2012.00851.x","article-title":"Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function","volume":"11","author":"Hearps","year":"2012","journal-title":"Aging Cell"},{"key":"2025021008000478200_r54","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nri3547","article-title":"Age-dependent dysregulation of innate immunity","volume":"13","author":"Shaw","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"2025021008000478200_r55","doi-asserted-by":"crossref","first-page":"970","DOI":"10.4049\/jimmunol.178.2.970","article-title":"Age-associated defect in human TLR-1\/2 function","volume":"178","author":"van Duin","year":"2007","journal-title":"J. Immunol."},{"key":"2025021008000478200_r56","first-page":"501","article-title":"Effects of aging on inflammation and hemostasis through the continuum of critical illness","volume":"2","author":"Kale","year":"2011","journal-title":"Aging Dis."},{"key":"2025021008000478200_r57","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2025021008000478200_r58","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2025021008000478200_r59","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat. Med."},{"key":"2025021008000478200_r60","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41569-019-0247-5","article-title":"Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease","volume":"17","author":"Jaiswal","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"2025021008000478200_r61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40778-018-0133-9","article-title":"Clonal hematopoiesis in aging","volume":"4","author":"Park","year":"2018","journal-title":"Curr. Stem Cell Rep."},{"key":"2025021008000478200_r62","doi-asserted-by":"crossref","first-page":"2324709620966863","DOI":"10.1177\/2324709620966863","article-title":"Chronic myelomonocytic leukemia presenting with polyserositis and seropositivity for rheumatoid arthritis","volume":"8","author":"Kunnumpurath","year":"2020","journal-title":"j. investig. med. high impact case rep."},{"key":"2025021008000478200_r63","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"2025021008000478200_r64","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"2025021008000478200_r65","doi-asserted-by":"crossref","first-page":"108326","DOI":"10.1016\/j.celrep.2020.108326","article-title":"TET2-loss-of-function-driven clonal hematopoiesis exacerbates experimental insulin resistance in aging and obesity","volume":"33","author":"Fuster","year":"2020","journal-title":"Cell Rep."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/210\/5\/580\/61468771\/ji2200412.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/210\/5\/580\/61468771\/ji2200412.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T08:02:05Z","timestamp":1739174525000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/210\/5\/580\/7932613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.2200412","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3]]},"published":{"date-parts":[[2023,1,20]]}}}